Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
株式のランク #7357
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
株価
$42.98
最終同期: 2024-06-21
時価総額
$1.62B
変化(1日)
0.01%
変化(1年)
0.00%
IL
取引 Taro Pharmaceutical Industries Ltd. (TARO)

カテゴリー

Taro Pharmaceutical Industries Ltd.(TARO)の営業利益率
August 2026 時点の営業利益率 TTM: 3.42%
Taro Pharmaceutical Industries Ltd. の最新の財務報告と株価によると、現在の営業利益率(TTM)は 3.42% です。2023 年末時点では 3.09% でした。
Taro Pharmaceutical Industries Ltd. の営業利益率の履歴(1999 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) 3.42% 0.00%
2024 3.42% 10.68%
2023 3.09% -90.59%
2022 32.84% -74.41%
2021 128.32% 235.56%
2020 38.24% -13.50%
2019 44.21% -3.43%
2018 45.78% -21.82%
2017 58.56% -9.39%
2016 64.63% 5.71%
2015 61.14% 7.89%
2014 56.67% 15.72%
2013 48.97% 12.32%
2011 43.60% 97.91%
2010 22.03% 24.96%
2009 17.63% 32.46%
2008 13.31% -27.98%
2007 18.48% -166.26%
2006 -27.89% -646.86%
2005 5.10% -2,933.33%
2004 -0.18% -100.76%
2003 23.68% -5.92%
2002 25.17% 15.30%
2001 21.83% 40.75%
2000 15.51% 20.23%
1999 12.90% 0.00%
同業他社の営業利益率
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。